Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac George

Showing results (261-270 of 336) with videos related to

Pageof 34
Sort By:
Cardiovascular Engineering and Technology|December 2, 2021
Right Heart Morphology of Candidate Patients for Transcatheter Tricuspid Valve InterventionsOmar K Khalique, Vladimir Jelnin, Andreas Hueske, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failureDavid Meier, Daire Grant, Chris Frawley, et al.
Journal of the American Heart Association|March 23, 2021
Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i TrialsMichael I Brener, Isaac George, Ioanna Kosmidou, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 30, 2007
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing databaseMark J Russo, Jonathan M Chen, Robert A Sorabella, et al.
Circulation|September 4, 2019
Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI TrialLars Søndergaard, Jeffrey J Popma, Michael J Reardon, et al.
The American Journal of Cardiology|July 30, 2020
Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)Steven J Yakubov, Nicolas M Van Mieghem, Michael J Reardon, et al.
Journal of the American Heart Association|August 13, 2021
Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal DiseaseTakuya Ogami, Paul Kurlansky, Hiroo Takayama, et al.
The Annals of Thoracic Surgery|April 22, 2020
Efficacy of Primary Surgical Versus Medical Intervention for Treatment of Left-Sided Infective EndocarditisStergios Gatzoflias, Matthew A Beier, Yuming Ning, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 17, 2020
Three-Year Outcomes With a Contemporary Self-Expanding Transcatheter Valve From the Evolut PRO US Clinical StudyMoritz C Wyler von Ballmoos, Michael J Reardon, Mathew R Williams, et al.
Pacing and Clinical Electrophysiology : PACE|March 5, 2019
Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patientsSarah K L Moore, Katherine H Chau, Salma Chaudhary, et al.
Pageof 34

Showing results (261-270 of 336) with videos related to

Sort By:
Pageof 34
Cardiovascular Engineering and Technology|December 2, 2021
Right Heart Morphology of Candidate Patients for Transcatheter Tricuspid Valve InterventionsOmar K Khalique, Vladimir Jelnin, Andreas Hueske, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failureDavid Meier, Daire Grant, Chris Frawley, et al.
Journal of the American Heart Association|March 23, 2021
Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i TrialsMichael I Brener, Isaac George, Ioanna Kosmidou, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 30, 2007
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing databaseMark J Russo, Jonathan M Chen, Robert A Sorabella, et al.
Circulation|September 4, 2019
Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI TrialLars Søndergaard, Jeffrey J Popma, Michael J Reardon, et al.
The American Journal of Cardiology|July 30, 2020
Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)Steven J Yakubov, Nicolas M Van Mieghem, Michael J Reardon, et al.
Journal of the American Heart Association|August 13, 2021
Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal DiseaseTakuya Ogami, Paul Kurlansky, Hiroo Takayama, et al.
The Annals of Thoracic Surgery|April 22, 2020
Efficacy of Primary Surgical Versus Medical Intervention for Treatment of Left-Sided Infective EndocarditisStergios Gatzoflias, Matthew A Beier, Yuming Ning, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 17, 2020
Three-Year Outcomes With a Contemporary Self-Expanding Transcatheter Valve From the Evolut PRO US Clinical StudyMoritz C Wyler von Ballmoos, Michael J Reardon, Mathew R Williams, et al.
Pacing and Clinical Electrophysiology : PACE|March 5, 2019
Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patientsSarah K L Moore, Katherine H Chau, Salma Chaudhary, et al.
Pageof 34